Skip to main content
. 2020 Oct 23;10:18206. doi: 10.1038/s41598-020-75144-z

Table 2.

Effect of UEDR on relative organ weight (ROW) in the subchronic oral toxicity study (× 10−3).

Index 28 days treatment (g/kg BW/day) 14 days withdrawal
Control 0.15 0.30 0.60 Control 0.15 0.30 0.60
Female ♀
Heart 3.94 ± 0.12 4.06 ± 0.07 4.24 ± 0.38 4.92 ± 0.08* 3.80 ± 0.11 3.42 ± 0.16 3.58 ± 0.19 3.90 ± 0.15
Liver 39.56 ± 0.26 38.36 ± 0.44 38.04 ± 0.51 36.98 ± 0.69** 37.00 ± 0.66 36.22 ± 0.54 37.48 ± 0.51 36.50 ± 0.62
Spleen 2.08 ± 0.12 2.16 ± 0.09 2.16 ± 0.10 2.04 ± 0.13 2.06 ± 0.68 1.96 ± 0.24 2.00 ± 0.04 2.00 ± 0.00
Lung 5.92 ± 0.19 6.22 ± 0.20 6.40 ± 0.14 6.68 ± 0.15* 6.34 ± 0.14 5.96 ± 0.21 6.40 ± 0.11 6.10 ± 0.00
Kidney 6.86 ± 0.17 7.24 ± 0.12 7.56 ± 0.13* 7.64 ± 0.21** 6.82 ± 0.14 6.66 ± 0.23 6.90 ± 0.21 6.43 ± 0.17
Stomach 98.38 ± 0.68 99.12 ± 0.82 100.16 ± 0.44 99.72 ± 0.48 99.34 ± 0.55 99.18 ± 0.53 99.68 ± 0.71 100.03 ± 0.33
Thymus 1.33 ± 0.04 1.39 ± 0.02 1.40 ± 0.02 1.43 ± 0.02 0.97 ± 0.01 0.98 ± 0.01 0.99 ± 0.01 0.98 ± 0.01
Ovary 0.59 ± 0.01 0.60 ± 0.01 0.58 ± 0.02 0.59 ± 0.01 0.54 ± 0.01 0.56 ± 0.01 0.54 ± 0.01 0.53 ± 0.02
Uterus 1.58 ± 0.04 1.58 ± 0.02 1.60 ± 0.02 1.61 ± 0.01 1.42 ± 0.02 1.48 ± 0.01 1.42 ± 0.02 1.44 ± 0.04
Male ♂
Heart 3.46 ± 0.13 3.48 ± 0.13 3.32 ± 0.19 3.38 ± 0.10 3.42 ± 0.08 3.46 ± 0.05 3.28 ± 0.92 3.25 ± 0.06
Liver 38.08 ± 0.31 37.54 ± 0.20 37.40 ± 0.17 37.04 ± 0.26* 35.18 ± 0.97 35.36 ± 1.05 35.98 ± 0.79 37.40 ± 0.15
Spleen 2.28 ± 0.08 2.20 ± 0.22 2.08 ± 0.12 2.10 ± 0.10 1.76 ± 0.07 2.02 ± 0.18 1.96 ± 0.10 2.05 ± 0.13
Lung 4.92 ± 0.24 6.16 ± 0.52 5.76 ± 0.25 6.42 ± 0.58* 5.48 ± 0.14 5.18 ± 0.10 5.32 ± 0.19 5.82 ± 0.48
Kidney 6.16 ± 0.24 6.92 ± 0.24 6.56 ± 0.33 7.18 ± 0.26* 5.90 ± 0.11 5.92 ± 0.08 5.88 ± 0.11 5.92 ± 0.48
Stomach 94.40 ± 2.06 92.54 ± 0.68 91.46 ± 0.79 88.90 ± 1.22 98.06 ± 0.43 96.74 ± 0.70 96.70 ± 0.25 98.15 ± 0.72
Thymus 1.34 ± 0.04 1.40 ± 0.01 1.39 ± 0.01 1.38 ± 0.02 1.01 ± 0.02 1.01 ± 0.01 1.00 ± 0.01 1.00 ± 0.02
Testicle 9.24 ± 0.22 9.34 ± 0.12 9.48 ± 0.07 9.40 ± 0.19 8.70 ± 0.07 8.51 ± 0.07 8.52 ± 0.12 8.62 ± 0.06

Data were presented as means ± SD (n = 6, per group for male and female rats, after 28-day administration; n = 4, per group for male and female rats, after 14-day withdrawal). *P < 0.05, **P < 0.01 vs. the control group.